Cargando…

Commentary: Variant Signal Peptides of Vaccine Antigen, FHbp, Impair Processing Affecting Surface Localization and Antibody-Mediated Killing in Most Meningococcal Isolates

Detalles Bibliográficos
Autores principales:	Liberator, Paul, Donald, Robert G. K., Balmer, Paul, Findlow, Jamie, Anderson, Annaliesa S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7677564/ https://www.ncbi.nlm.nih.gov/pubmed/33240223 http://dx.doi.org/10.3389/fmicb.2020.538209

Ejemplares similares

Variant Signal Peptides of Vaccine Antigen, FHbp, Impair Processing Affecting Surface Localization and Antibody-Mediated Killing in Most Meningococcal Isolates
por: da Silva, Ronni A. G., et al.
Publicado: (2019)

Corrigendum: Variant Signal Peptides of Vaccine Antigen, FHbp, Impair Processing Affecting Surface Localization and Antibody-Mediated Killing in Most Meningococcal Isolates
por: da Silva, Ronni A. G., et al.
Publicado: (2020)

Selection of diverse strains to assess broad coverage of the bivalent FHbp meningococcal B vaccine
por: Harris, Shannon L., et al.
Publicado: (2020)

27. Immunologic Hyporesponsiveness with Subsequent Dosing of Meningococcal Vaccines: Re-Evaluating the Current Paradigm
por: Findlow, Jamie, et al.
Publicado: (2021)

MenB-FHbp Vaccine Protects Against Diverse Meningococcal Strains in Adolescents and Young Adults: Post Hoc Analysis of Two Phase 3 Studies
por: Beeslaar, Johannes, et al.
Publicado: (2020)

A review of complement sources used in serum bactericidal assays for evaluating immune responses to meningococcal ACWY conjugate vaccines
por: Findlow, Jamie, et al.
Publicado: (2019)

6. Pentavalent Meningococcal (MenABCWY) Vaccine is Safe and Well Tolerated With Immunogenicity Noninferior to Coadministered MenB-FHbp and MenACWY-CRM in a Phase 2 Study of Healthy Adolescents and Young Adults
por: Peterson, James, et al.
Publicado: (2020)

Sex, Age, and Race Effects on Immunogenicity of MenB-FHbp, A Bivalent Meningococcal B Vaccine: Pooled Evaluation of Clinical Trial Data
por: Beeslaar, Johannes, et al.
Publicado: (2020)

Evolution of invasive meningococcal disease epidemiology in Europe, 2008 to 2017
por: Nuttens, Charles, et al.
Publicado: (2022)

Meningococcal B vaccine antigen FHbp variants among disease-causing Neisseria meningitidis B isolates, Italy, 2014–2017
por: Carannante, Anna, et al.
Publicado: (2020)

Epidemiology of invasive meningococcal disease worldwide from 2010–2019: a literature review
por: Pardo de Santayana, Carmen, et al.
Publicado: (2023)

A Broadly Cross-Reactive Monoclonal Antibody Against an Epitope on the N-terminus of Meningococcal fHbp
por: Vu, David M., et al.
Publicado: (2012)

Meningococcal serogroup B vaccines: Estimating breadth of coverage
por: Donald, Robert G. K., et al.
Publicado: (2016)

Vaccination strategies for the prevention of meningococcal disease
por: Vuocolo, Scott, et al.
Publicado: (2018)

Human Factor H (FH) Impairs Protective Meningococcal Anti-FHbp Antibody Responses and the Antibodies Enhance FH Binding
por: Costa, Isabella, et al.
Publicado: (2014)

ERRATUM: A Broadly Cross-Reactive Monoclonal Antibody Against an Epitope on the N-terminus of Meningococcal fHbp
por: Vu, David M., et al.
Publicado: (2013)

Thermoregulation of Meningococcal fHbp, an Important Virulence Factor and Vaccine Antigen, Is Mediated by Anti-ribosomal Binding Site Sequences in the Open Reading Frame
por: Loh, Edmund, et al.
Publicado: (2016)

A Newly-Identified Polymorphism in Rhesus Macaque Complement Factor H Modulates Binding Affinity for Meningococcal FHbp
por: Konar, Monica, et al.
Publicado: (2015)

An Analysis of the Sequence Variability of Meningococcal fHbp, NadA and NHBA over a 50-Year Period in the Netherlands
por: Bambini, Stefania, et al.
Publicado: (2013)

Crystal structure reveals vaccine elicited bactericidal human antibody targeting a conserved epitope on meningococcal fHbp
por: López-Sagaseta, Jacinto, et al.
Publicado: (2018)

Updated Recommendations for Use of MenB-FHbp Serogroup B Meningococcal Vaccine — Advisory Committee on Immunization Practices, 2016
por: Patton, Monica E., et al.
Publicado: (2017)

Performance of a Four-Antigen Staphylococcus aureus Vaccine in Preclinical Models of Invasive S. aureus Disease
por: Scully, Ingrid L., et al.
Publicado: (2021)

Systematic literature review of the impact and effectiveness of monovalent meningococcal C conjugated vaccines when used in routine immunization programs
por: Tin Tin Htar, Myint, et al.
Publicado: (2020)

2722. Effects of Sex, Age, and Race on Immunogenicity of MenB-FHbp, a Bivalent Meningococcal B Vaccine: A Pooled Evaluation of Clinical Trial Data
por: Beeslaar, Johannes, et al.
Publicado: (2019)

Covering all the Bases: Preclinical Development of an Effective Staphylococcus aureus Vaccine
por: Scully, Ingrid L., et al.
Publicado: (2014)

Global Meningococcal Initiative: guidelines for diagnosis and confirmation of invasive meningococcal disease
por: VÁZQUEZ, J. A., et al.
Publicado: (2016)

4CMenB vaccine induces elite cross-protective human antibodies that compete with human factor H for binding to meningococcal fHbp
por: Veggi, Daniele, et al.
Publicado: (2020)

Contribution of factor H-Binding protein sequence to the cross-reactivity of meningococcal native outer membrane vesicle vaccines with over-expressed fHbp variant group 1
por: Marini, Arianna, et al.
Publicado: (2017)

Correlation of Group C Meningococcal Conjugate Vaccine Response with B- and T-Lymphocyte Activity
por: Wing, James B., et al.
Publicado: (2012)

Correction: Correlation of Group C Meningococcal Conjugate Vaccine Response with B- and T-Lymphocyte Activity
por: Wing, James B., et al.
Publicado: (2012)

Persistence of antibodies in laboratory staff immunized with quadrivalent meningococcal polysaccharide vaccine
por: Elias, Johannes, et al.
Publicado: (2013)

Molecular characterization of invasive Neisseria meningitidis isolates collected in Lithuania (2009-2019) and estimation of serogroup B meningococcal vaccine 4CMenB and MenB-Fhbp coverage
por: Sereikaitė, Emilija, et al.
Publicado: (2023)

A Review of Meningococcal Disease and Vaccination Recommendations for Travelers
por: Serra, Lidia C., et al.
Publicado: (2018)

FHbp variants among meningococci of serogroup B in Italy: Evolution and selective pressure, 2014–2017
por: Lo Presti, Alessandra, et al.
Publicado: (2023)

Impact of meningococcal vaccination on carriage and disease transmission: A review of the literature
por: Balmer, Paul, et al.
Publicado: (2018)

Epidemiologic Trends, Global Shifts in Meningococcal Vaccination Guidelines, and Data Supporting the Use of MenACWY-TT Vaccine: A Review
por: Presa, Jessica, et al.
Publicado: (2019)

A Meningococcal Outer Membrane Vesicle Vaccine with Overexpressed Mutant FHbp Elicits Higher Protective Antibody Responses in Infant Rhesus Macaques than a Licensed Serogroup B Vaccine
por: Beernink, Peter T., et al.
Publicado: (2019)

Ribotype Classification of Clostridioides difficile Isolates Is Not Predictive of the Amino Acid Sequence Diversity of the Toxin Virulence Factors TcdA and TcdB
por: Li, Zhenghui, et al.
Publicado: (2020)

A physician’s guide to the 2-dose schedule of MenB-FHbp vaccine
por: McDaniel, Angee, et al.
Publicado: (2019)

Review of clinical studies comparing meningococcal serogroup C immune responses induced by MenACWY-TT and monovalent serogroup C vaccines
por: Serra, Lidia, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rtuhc6e1idj4uiuiob6vbntnri